COMPASS PATHWAYS INC.

Lobbying for COMPASS PATHWAYS INC. · Biotechnology company

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 17, 2026

Expenses

$130,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

New York

Official filing document

Government bodies contacted 4

Drug Enforcement Administration (DEA)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Budget/Appropriations

Discussions regarding legislative and regulatory issues, including appropriations, pertaining to the use and application of psychedelic medicines. Issues pertaining to controlled substances rescheduling

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.